<DOC>
	<DOCNO>NCT00210314</DOCNO>
	<brief_summary>Aim study establish prospective , randomized clinical trial activity primary chemotherapy contain high dose-methotrexate , alone combine high dose cytarabine , patient primary central nervous system lymphoma</brief_summary>
	<brief_title>Phase II Trial Combined Modality Treatment Primary Central Nervous System Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>1 . Histological cytological diagnosis nonHodgkin 's lymphoma . 2 . Diagnostic sample obtain stereotactic surgical biopsy , CSF cytology examination vitrectomy . 3 . Disease exclusively localize central nervous system , cranial nerve eye . 4 . Untreated patient ( patient treat steroid alone eligible ) . 5 . At least one measurable lesion . 6 . Age 18 75 year . 7 . ECOG performance status &lt; 3 8 . HBsAgnegative Ab antiHCVnegative serologic status . 9 . No known HIV disease immunodeficiency . 10 . Adequate bone marrow ( PLT &gt; 100000 mm3 , Hb ≥ 9 g/dl , ANC ≥ 2.000 mm3 ) , renal ( creatinine clearance ≥ 60 mL/min ) , cardiac ( VEF ≥ 50 % ) , hepatic function ( total serum bilirubin &lt; 3 mg/dL , AST/ALT gGT &lt; 2 per upper normal limit value ) . 11 . No previous concurrent malignancy exception surgically cured cervical intraepithelial neoplasia type 1 ( CIN1 ) localize nonmelanomatous skin cancer cancer without evidence disease since least 5 year ( patient previous lymphoma diagnosis exclude ) . 12 . Absence familial , sociological geographical condition potentially hamper compliance study protocol followup schedule . 13 . Nonpregnant nonlactating status female patient . Adequate contraceptive measure study participation sexually active patient childbearing potential . 14 . No concurrent treatment experimental drug . 15 . Informed consent sign patient registration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>